Asymmetrex: Funding, Investors & Team (Sep 2026)
Asymmetrex® is a private, for-profit biotechnology company that specializes in technologies for stem cell medicine. Asymmetrex®'s founder, President and CEO is a leading authority on the unique properties of adult tissue stem cells. Asymmetrex holds a rich portfolio of intellectual property for technologies that address major barriers to success in regenerative medicine. These include patented methods for mass-producing adult tissue stem cells and their differentiated derivatives; counting adult tissue stem cells; engineering adult tissues stem cells; and evaluating effects of new drug candidates on adult tissue stem cells. Current products include renewable adult tissue stem cells strains for research applications and exclusive licensing of technologies for specific fields of use. In 2023, the company introduced the first-ever rapid-counting tissue stem cell calculators. The calculators are available free online at https://asymmetrex.com/stem-cell-counting-center. This first generation of free tissue stem cell calculators are applicable to commonly used human HSC-containing preparations and human adipose MSC-containing preparations. These and next-generation stem cell calculators will be used to develop the first commercial automated electronic tissue stem cell counters.
Asymmetrex has raised $1.8M across 1 funding round on record, the most recent an undisclosed round of $1.8M announced in Oct 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Asymmetrex Company Profile and Key Stats
Latest funding round on record: Oct 2024.
Asymmetrex Funding Rounds
Asymmetrex Founders and Leadership Team
Contact details for the Asymmetrex team: 1 of 1 has an email address on file.
Start 14-day free trial →Asymmetrex Funding Compared to Other Biotechnology Startups
Asymmetrex's latest round of $1.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Asymmetrex in Biotechnology and Boston
Companies Similar to Asymmetrex
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Asymmetrex Funding FAQs
What does Asymmetrex do?
Asymmetrex® is a private, for-profit biotechnology company that specializes in technologies for stem cell medicine. Asymmetrex®'s founder, President and CEO is a leading authority on the unique properties of adult tissue stem cells. Asymmetrex holds a rich portfolio of intellectual property for technologies that address major barriers to success in regenerative medicine. These include patented methods for mass-producing adult tissue stem cells and their differentiated derivatives; counting adult tissue stem cells; engineering adult tissues stem cells; and evaluating effects of new drug candidates on adult tissue stem cells. Current products include renewable adult tissue stem cells strains for research applications and exclusive licensing of technologies for specific fields of use. In 2023, the company introduced the first-ever rapid-counting tissue stem cell calculators. The calculators are available free online at https://asymmetrex.com/stem-cell-counting-center. This first generation of free tissue stem cell calculators are applicable to commonly used human HSC-containing preparations and human adipose MSC-containing preparations. These and next-generation stem cell calculators will be used to develop the first commercial automated electronic tissue stem cell counters.
How much funding has Asymmetrex raised?
Asymmetrex has raised $1.8M across 1 round on record. The most recent is an undisclosed round of $1.8M announced in Oct 2024.
When did Asymmetrex last raise funding?
Asymmetrex's most recent funding round on record is an undisclosed round of $1.8M, announced in Oct 2024.
Who founded Asymmetrex?
FundedIQ lists James L Sherley (Founder) at Asymmetrex.
Where is Asymmetrex headquartered?
Asymmetrex is based in Boston, Massachusetts, United States.
How many employees does Asymmetrex have?
Asymmetrex is in the 1-10 employee band.
How does Asymmetrex's funding compare to other Biotechnology startups?
Asymmetrex's latest round of $1.8M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Asymmetrex Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Asymmetrex is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.